SDZ-220-581 is a potent, competitive antagonist at the NMDA glutamate receptor subtype, reversed haloperidol-induced catalepsy in rats, a widely used model of Parkinson's disease.

Product information

CAS Number: 179411-94-0

Molecular Weight: 386.77

Formula: C16H20ClN2O5P

Chemical Name: (2S)-2-amino-3-[2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-yl]propanoic acid amine

Smiles: N.N[C@@H](CC1=CC(=CC(CP(O)(O)=O)=C1)C1=CC=CC=C1Cl)C(O)=O

InChiKey: JSKZYMJZKPLCNJ-RSAXXLAASA-N

InChi: InChI=1S/C16H17ClNO5P.H3N/c17-14-4-2-1-3-13(14)12-6-10(8-15(18)16(19)20)5-11(7-12)9-24(21,22)23;/h1-7,15H,8-9,18H2,(H,19,20)(H2,21,22,23);1H3/t15-;/m0./s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥360 days if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.